Literature DB >> 9012435

Penetrating injuries of the neck: selective management evolving.

M L Klyachkin1, M Rohmiller, W E Charash, D A Sloan, P A Kearney.   

Abstract

Since 1990, a selective management algorithm has been used in our Trauma Center to treat 91 patients with penetrating neck injuries. Group A (n = 37) sustained zone I, zone III, or multiple-zone injuries; Group B (n = 54) sustained zone II injuries [most (55, 66.4%) from gunshot or shotgun wounds]. Nineteen Group A and 21 Group B patients required mandatory neck exploration. Vascular or aerodigestive tract injuries were found and adequately repaired in 15 Group A and 11 Group B patients. The superficial wounds of three Group A and seven Group B patients were closed, and the patients were observed for 24 hours. The remaining 15 Group A and 24 Group B patients underwent routine angiogram, arbitrary barium swallow, and, if necessary, esophagoscopy. Two of these Group B patients required surgery for common carotid artery injuries. One patient died 4 months later because of missed vertebral artery pseudoaneurysm. Overall mortality and complication rates were 6 and 1 per cent. Unnecessary exploration was avoided in 52 per cent of cases regardless of the location of the wound. Mortality and morbidity rates were acceptable. Patients with penetrating neck injuries could be safely managed selectively regardless of the injury zone.

Entities:  

Mesh:

Year:  1997        PMID: 9012435

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

1.  Multiple-projectile penetrating neck injury from a modified nail-containing gas pistol.

Authors:  Dimitar Dimitrov Pazardzhikliev
Journal:  Balkan Med J       Date:  2014-09-01       Impact factor: 2.021

Review 2.  Surgeon-performed ultrasound: its use in clinical practice.

Authors:  G S Rozycki
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

3.  [Impalement injury of the neck].

Authors:  E Oestreicher; O Koch; B Brücher
Journal:  HNO       Date:  2003-04-08       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.